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everal kinases phosphorylate vimentin, the most
common intermediate filament protein, in mitosis.
Aurora-B and Rho-kinase regulate vimentin filament
separation through the cleavage furrow-specific vimentin
phosphorylation. Cdk1 also phosphorylates vimentin from
prometaphase to metaphase, but its significance has re-
mained unknown. Here we demonstrated a direct interac-
tion between Plk1 and vimentin-Ser55 phosphorylated by
Cdk1, an event that led to Plk1 activation and further vi-
mentin phosphorylation. Plk1 phosphorylated vimentin at
 

 
1 mol phosphate/mol substrate, which partly inhibited
its filament forming ability, in vitro. Plk1 induced the phos-
S
 
phorylation of vimentin-Ser82, which was elevated from
metaphase and maintained until the end of mitosis. This
elevation followed the Cdk1-induced vimentin-Ser55
phosphorylation, and was impaired by Plk1 depletion.
Mutational analyses revealed that Plk1-induced vimentin-
Ser82 phosphorylation plays an important role in vimen-
tin filaments segregation, coordinately with Rho-kinase
and Aurora-B. Taken together, these results indicated a
novel mechanism that Cdk1 regulated mitotic vimentin
phosphorylation via not only a direct enzyme reaction but
also Plk1 recruitment to vimentin.
 
Introduction
 
Mitosis is the fundamental process by which cellular contents
are segregated into two daughter cells. Protein phosphorylation
is responsible not only for the initiation of mitosis but also for
mitotic morphological changes including the rearrangements of
three major cytoskeletons (Nigg, 2001). These changes are reg-
ulated not only by Cdk1 but also additional kinases such as
orthologs of fly Polo (Barr et al., 2004) or Aurora (Carmena
and Earnshaw, 2003) or fungus NIMA (Nigg, 2001). For exam-
ple, Polo-like kinase 1 (Plk1) participates in several events in-
cluding centrosome maturation, bipolar spindle formation, and
chromosome segregation (Barr et al., 2004).
Intermediate filaments (IFs) are one of the three major cy-
toskeletal networks, together with actin filaments and microtu-
bules. Vimentin is the most abundant IF protein expressed in
mesenchymal cells and in a variety of cultured cells and tumors
(Fuchs and Weber, 1994; Chang and Goldman, 2004). IFs are
dramatically reorganized during mitosis, and this reorganization
is considered to be controlled by IF protein phosphorylation (Ina-
gaki et al., 1987, 1996). For example, Cdk1 phosphorylates vi-
mentin from prometaphase to metaphase (Tsujimura et al., 1994).
On the other hand, Aurora-B (Goto et al., 2003) and Rho-kinase
(Goto et al., 1998) phosphorylate vimentin specifically at the
cleavage furrow from anaphase to the end of mitosis. Mutational
studies revealed that efficient IF separation largely depends on
Aurora-B and Rho-kinase activity (Yasui et al., 2001; Goto et al.,
2003). However, there is little information on the significance of
vimentin phosphorylation by Cdk1 (Yasui et al., 2001).
In the present study, we present a novel mechanism indicat-
ing that Cdk1 governs mitotic vimentin phosphorylation not only
by a direct enzyme–substrate reaction but also through Plk1 re-
cruitment to Cdk1 induced vimentin phosphorylation. This event
then induces Plk1 activation and further vimentin phosphorylation.
 
Results and discussion
 
Plk1 can bind to vimentin phosphorylated 
by Cdk1
 
Vimentin phosphorylation is spatiotemporally regulated by
several kinases during mitosis (Inagaki et al., 1996). Fig. 1 A
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shows mitotic vimentin phosphorylation at Ser55, Ser71, and
Ser72, which were identified as phosphorylation sites specific
to Cdk1 (Chou et al., 1991; Kusubata et al., 1992), Rho-kinase
(Goto et al., 1998), and Aurora-B (Goto et al., 2003), respec-
tively. Cdk1 phosphorylates vimentin from prometaphase to
metaphase, and this phosphorylation occurs throughout the cyto-
plasm (Tsujimura et al., 1994). On the other hand, Rho-kinase
and Aurora-B coordinately regulate the cleavage furrow-specific
vimentin phosphorylation from anaphase to cytokinesis (Goto et
al., 1998, 2003; Yasui et al., 2001). Vimentin mutation at Rho-
kinase and Aurora-B phosphorylation sites induced the for-
mation of IF bridges (
 

 
50% of postmitotic cells; Fig. 1 B)
between two daughter cells (Yasui et al., 2001; Goto et al.,
2003). However, vimentin filament segregation appeared to
occur successfully in most of the cells expressing vimentin
mutated at Cdk1 phosphorylation sites (Fig. 1 B), although 3–5%
of postmitotic cells showed the IF bridge phenotype (Yasui et
al., 2001). Thus, the significance of vimentin phosphorylation
by Cdk1 remained unknown.
Plk1 was reported to bind to a phosphoserine (pS)- or
phosphothreonine (pT)-containing peptide through its polo-
box domain (PBD; Elia et al., 2003a). To examine whether
Plk1 interacts with vimentin phosphorylated by Cdk1, vimen-
tin phosphorylated by Cdk1 was subjected to Far Western
analysis using GST-PBD proteins. Fig. 1 C shows that
GST-PBD wild type (WT) directly interacted with vimentin
phosphorylated by Cdk1, but not with nonphosphorylated vi-
mentin. This phenomenon was not observed in the case of
GST-PBD-HK538/540AA, which cannot bind phosphopro-
teins (Elia et al., 2003b), suggesting specific binding between
PBD and vimentin phosphorylated by Cdk1 (Fig. 1 C). Next,
we examined the phosphorylation site essential for this inter-
action. Because Ser41 and Ser55 on vimentin were reported to
be phosphorylated by Cdk1 (Chou et al., 1991; Kusubata et
al., 1992), we did a competition assay using PV55, PV41 (cor-
responding to vimentin phosphorylated at Ser55 or Ser41, re-
spectively), V55 peptide (corresponding to vimentin unphos-
phorylated at Ser55; Tsujimura et al., 1994), or EV55 peptide
(corresponding to vimentin in which Ser55 is changed to
Glu). As shown in Fig. 1 D, binding to vimentin was inhibited
by preincubation of GST-PBD-WT with PV55, but not with
TBS (control), V55, EV55, or PV41: with regard to Plk1
binding to vimentin, Ser55 mutation to Glu did not mimic
Ser55 phosphorylation. PV55 phosphopeptide contains Ser-
pSer-Pro reported to be a preferred consensus sequence for a
Plk1-binding motif (Elia et al., 2003a). GST pull-down assay
revealed that PBD-WT bound to vimentin-Ser55 phosphory-
lated in mitotic cell extract but not nonphosphorylated vi-
mentin in interphase extract (Fig. 1 E). Thus, these results
indicated that Plk1 may directly bind to vimentin-Ser55 phos-
phorylated by Cdk1.
 
The binding of vimentin phosphorylated 
by Cdk1 stimulates the catalytic activity 
of Plk1, and induces further vimentin 
phosphorylation
 
The above specific binding led us to examine its effect on the
catalytic activity of Plk1. First, we used casein as a control sub-
strate. As shown in Fig. 2, A and B, the preincubation of Plk1
with PV55 increased its kinase activity toward casein about
three times over that without peptide. However, only marginal
stimulation was observed in the case of V55 or PV41, confirm-
ing the peptide specificity of the Plk1 activation (Fig. 2 A).
To determine if a similar Plk1 activation also occurred in
the context of a full-length protein, vimentin was preincubated
with or without Cdk1 in the absence of radioactive ATP and
then incubated with or without Plk1 in the presence of radioac-
tive ATP. Plk1 phosphorylated vimentin pretreated with Cdk1
approximately five times more than without Cdk1 (Fig. 2, C
and D). Our observations suggest that Plk1 binding to phos-
phorylated vimentin-Ser55 induces Plk1 activation and further
vimentin phosphorylation.
Figure 1. Plk1 binds to vimentin phosphorylated by Cdk1. (A) Site-specific
phosphorylation of vimentin during metaphase/anaphase in U251 cells.
(B) Metaphase or postmitotic T24 cells expressing vimentin WT or vimentin
mutated at Cdk1 (mutant I: Ser41 and Ser55) or Rho-kinase  Aurora-B
(mutant II: Ser6, Ser24, Ser38, Ser46, Ser64, Ser65, Ser71, Ser72, and
Ser86) phosphorylation sites (Yasui et al., 2001). Green color represents
the staining with anti-vimentin (A and B) or the site- and phosphorylation
state–specific antibody for Ser55, Ser71, or Ser72 on vimentin (A). DNA
was also stained with propidium iodide (red). (C) Specific interaction of
Plk1 with vimentin phosphorylated by Cdk1. Vimentin was incubated with
(Cdk1) or without (Control) Cdk1. Each sample was then subjected to im-
munoblotting with 4A4 (P-ser55) or Far Western blotting using GST-PBD.
(D) Site specificity of plk1 determined by competition assay. After Far
Western blotting (C and D), transferred membrane was stained with Coo-
massie brilliant blue (CBB). (E) GST pull-down assay using GST-PBD. Each
sample was prepared as described in Materials and methods, and then sub-
jected to immunoblotting with 4A4 (P-Ser55) and anti-vimentin antibody.
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Plk1 phosphorylates vimentin at Ser82, 
which partly inhibits the filament forming 
ability of vimentin
 
We next examined whether vimentin is a good substrate for
Plk1. Vimentin was phosphorylated by GST-Plk1-WT, but not
by -K82R (Fig. 3 A): the phosphorylation level increased in a
time-dependent manner and reached 
 

 
1 mol of phosphate/mol
of protein at 120 min (Fig. 3 C). Immunological analyses re-
vealed that Plk1 phosphorylated Ser82, but not Ser6, Ser28,
Ser33, Ser38, Ser50, Ser55, Ser71, and Ser72 on vimentin in
vitro (Fig. 3 A). In addition, Ser82 phosphorylation was ob-
served in COS-7 cells expressing Plk1 T210D (a constitutively
active mutant) but not K82R (Fig. 3 B). These observations
suggested that Plk1 induced vimentin phosphorylation at Ser82
likely through a direct enzyme–substrate reaction.
To examine the effect of vimentin phosphorylation by
Plk1 on vimentin filament forming ability, soluble vimentin was
treated with or without Plk1 and then incubated under condi-
tions favoring polymerization. After incubation, each sample
was separated into supernatant and pellet fractions by centrifu-
gation. Plk1 treatment partly inhibited the filament forming
ability of vimentin, so that some Plk1-treated vimentin was re-
covered from the supernatant fraction (Fig. 3 D). Although the
amounts of Plk1-treated vimentin in the supernatant fraction
were smaller that those in the pellet fraction, there was little dif-
ference in the MO82 immunoreactivity between these two frac-
tions (Fig. 3 D), indicating that most of the Ser82-phosphory-
lated vimentin had lost its filament forming ability in vitro.
 
Vimentin phosphorylation motif for Plk1
 
The consensus Plk1 phosphorylation motif was reported to
be D/E-X-pS/pT-
 

 
-X-D/E (
 

 
; a hydrophobic amino acid) in
which the 
 

 
3 position is preferred but not essential for kinase
recognition (Nakajima et al., 2003). Because the vimentin se-
quence around Ser82 did not completely match the above
consensus (Fig. 3 E), we examined which amino acid(s) sur-
Figure 2. Plk1 increases its catalytic activity via its binding to vimentin
phosphorylated at Ser55 by Cdk1. (A) After GST-Plk1-WT was preincu-
bated with PV55, PV41, or V55 (Tsujimura et al., 1994) for 5 min at RT,
casein was phosphorylated by above Plk1. The SDS-PAGE gel was
stained with CBB and then subjected to autoradiography (32P). (B) Time
course of Plk1 kinase activity with or without PV55. (C) After vimentin was
preincubated with or without Cdk1, each sample was further incubated
with or without Plk1. The total amount of vimentin was determined by
CBB. The phosphorylation of vimentin at Ser55 was detected by immuno-
blotting using 4A4. The incorporation of radioactivity was analyzed by
autoradiography. (D) Quantification of Plk1 kinase activity indicated in C.
Figure 3. Plk1 phosphorylates vimentin at Ser82. (A) Vimentin was incu-
bated with GST-Plk1-WT or -K82R (a kinase dead mutant). The incorpora-
tion of radioactivity into vimentin was analyzed by autoradiography and
the total amount of vimentin was determined by CBB. Each sample was
also subjected to immunoblotting with each site- and phosphorylation
state–specific antibody. The following were used as a positive control for
each antibody (phosphorylated vimentin, PV): vimentin phosphorylated by
protein kinase A (PKA) for MO6 (P-Ser6) and TM28 (P-Ser28), by PKC for
YT33 (P-Ser33) and TM50 (P-Ser50), by Ca2/calmodulin-dependent pro-
tein kinase II for TM38 (P-Ser38) and MO82 (P-Ser82), by Cdk1 for 4A4
(P-Ser55), by Rho-kinase for TM71 (P-Ser71), and by Aurora-B for YG72
(P-Ser72), respectively. As a negative control, nonphosphorylated vimen-
tin (V) was also immunoblotted. (B) COS-7 cells were transfected with myc-
Plk1-T210D or -K82R. Green, red, or blue color represents vimentin-
phosphoSer82 (MO82), the expression of Plk1 mutants (Myc), or DNA,
respectively. (C) Time course of vimentin phosphorylation by Plk1. (D) Vi-
mentin was preincubated with or without Plk1, and then incubated in the
polymerization buffer (Goto et al., 1998) at 37C for 60 min further. After
incubation, each sample was centrifuged at 12,000 g. The supernatant (s)
and the precipitate (p) fractions were analyzed using SDS-PAGE, then, the
gel was subjected to staining with CBB or the immunoblotting with MO82
(P-Ser82). (E) The sequence of residues 76–85 on vimentin and of various
vimentin mutant peptides. (F) Plk1 activity toward each vimentin peptide
indicated in E was quantified as a percentage of the radioactivity of each
peptide relative to that of WT peptide.
 o
n
 D
ecem
ber 15, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published October 31, 2005
 JCB • VOLUME 171 • NUMBER 3 • 2005434
 
rounding Ser82 are important for Plk1 phosphorylation, using
synthetic vimentin peptides (residues 76–85) in which each
amino acid was changed to Ala (Fig. 3 E). Compared with
WT sequence, the substitution of Asp81 (81DA) or Val83
(83VA) strongly reduced peptide phosphorylation, but the
substitution of Asp84 (84DA) increased the phosphorylation
(Fig. 3 F). These results suggest that the position of an acidic
amino acid is important for vimentin phosphorylation by
Plk1: Asp at the 
 

 
1 position is required for Plk1 phosphory-
lation, but Asp at the 
 

 
2 position has an inhibitory effect. In
addition, a hydrophobic amino acid at the 
 

 
1 position is essen-
tial for Plk1 recognition, in line with the report by Nakajima et
al. (2003).
 
Plk1 regulates the elevation of vimentin-
Ser82 phosphorylation, which follows 
vimentin-Ser55 phosphorylation by 
Cdk1, in mitosis
 
We investigated the temporal and spatial distribution of vimen-
tin-Ser55 and vimentin-Ser82 phosphorylation at each stage of
mitosis. As shown in Fig. 4, A and B, Ser55 phosphorylation
occurred from prometaphase to metaphase, as reported previ-
ously (Tsujimura et al., 1994). Although Ser82 phosphoryla-
tion was weakly observed even in interphase, the elevation
of Ser82 phosphorylation occurred from metaphase (from
prometaphase in some cells) and was maintained until the end
of mitosis. These results indicated that the elevation of vimen-
tin-Ser82 phosphorylation occurred just after the initiation of
vimentin-Ser55 phosphorylation by Cdk1.
To examine the relationship between Ser55 and Ser82
phosphorylation, we transfected T24 cells with vimentin WT or
its mutant in which Ser55 is changed into Ala (S55A). 48 h after
transfection, the level of Ser82 phosphorylation significantly re-
duced in cells expressing S55A, compared with WT (Fig. 4, C
and D). These results suggested that Ser55 phosphorylation plays
an important role in mitotic elevation of Ser82 phosphorylation.
To examine whether Plk1 regulates vimentin-Ser82 phos-
phorylation, we depleted endogenous Plk1 using small interfer-
ence RNA (siRNA), as reported previously (Liu and Erikson,
2002). 48 h after transfection, Plk1 expression was signifi-
cantly reduced in Plk1 siRNA–treated cells compared with
control cells, although no significant difference was observed
in vimentin expression (Fig. 4 F). Plk1 depletion diminished
vimentin-Ser82 phosphorylation in mitosis but not in inter-
phase, whereas no significant reduction was observed in the
level of vimentin-Ser55 phosphorylation (Fig. 4, E and F).
These results suggested that Plk1 regulates the mitotic eleva-
tion of vimentin-Ser82 phosphorylation.
 
Effects of vimentin-Ser82 
phosphorylation by Plk1 on cytokinesis
 
We constructed a mutant vimentin in which Ser82 is changed
to Glu (S82E), which is assumed to mimic Ser82 phosphoryla-
tion. Exogenous WT expression induced the formation of a fil-
amentous IF network in T24 cells (expressing no endogenous
vimentin), similar to the network observed in cells expressing
endogenous vimentin (Fig. 5 A). On the other hand, S82E mu-
tant no longer formed a clear filamentous IF network: instead,
the dot-like IF structures and short filaments were distributed
diffusely in the cytoplasm. Together with in vitro data (Fig. 3 D),
these results indicated that Plk1, as well as Aurora-B and Rho-
kinase, may participate in the reorganization of vimentin fila-
ments through vimentin phosphorylation.
To investigate the significance of vimentin-Ser82 phos-
phorylation in mitosis, we constructed a series of mutant vi-
mentin in which phosphorylation site(s) are changed to Ala,
and transfected then with T24 (type III IF–deficient) cells (Fig.
5 B). IF bridge and multinuclear phenotype were frequently
observed in cells expressing vimentin with mutations in Rho-
kinase and Aurora-B sites (52.6 
 

 
 2.6%) as compared with
WT (2.1 
 

 
 0.5%): this observation was consistent with our
Figure 4. Plk1 depletion impaired the elevation of vimentin-Ser82 phos-
phorylation in mitosis. (A) Cell cycle–dependent phosphorylation of vi-
mentin-Ser55 and vimentin-Ser82 during mitosis in U251 cells. Green
color represents vimentin phosphorylated at Ser55 (4A4) or at Ser82
(MO82). DNA was stained with propidium iodide (red). (B) Interphase (I)
or early mitotic (M) U251 cell lysates were subjected to immunoblotting
with 4A4 or MO82 antibody. (C) T24 cells were transfected with pDR2
carrying vimentin WT or S55A. 48 h after transfection, cells were stained
with anti-vimentin antibody (green) and MO82 (red) and DAPI (blue). (D)
44 h transfection, cells were synchronized at the prometaphase by the
addition of nocodazole. After 4 h (48 h after transfection), interphase or
early mitotic cell lysate were subjected to immunoblotting analysis with
MO82 or anti-vimentin antibody. (E) 48 h after transfection with or with-
out Plk1 siRNA duplex, U251 cells were stained with anti-Plk1, MO82,
4A4, or anti-vimentin antibody (green), and DAPI (blue). (F) 36 h transfec-
tion, cells were synchronized at the prometaphase by the addition of no-
codazole. After 12 h (48 h after transfection), interphase or early mitotic
cell lysate were subjected to immunoblotting analysis with anti-Plk1,
MO82, 4A4, or anti-vimentin antibody.
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previous reports (Goto et al., 2003). Additional Ser82 mutation
showed synergistic effects (63.3 
 

 
 3.3%) in the IF bridge for-
mation and multinucleate cell, although single mutation at
Ser82 showed a little effect (S82A; 4.86 
 

 
 0.9%, Fig. 5 B).
These mutational analyses revealed that Plk1 might play im-
portant roles in the correct separation of vimentin filaments,
together with Rho-kinase and Aurora-B.
We propose that Cdk1 phosphorylation induces Plk1-medi-
ated reorganization of vimentin filaments (Fig. 5 C). According
to our model, Cdk1 phosphorylates vimentin at Ser55 from
prometaphase to metaphase (step 1), then, Plk1 is recruited to
phosphoSer55 on vimentin via its PBD (step 2). The binding of
the PBD to phosphorylated vimentin-Ser55 serves to increase not
only the catalytic activity of Plk1 but also the accessibility of the
activated Plk1 to vimentin (Fig. 2). This mechanism facilitates
vimentin phosphorylation at Ser82 by Plk1 (step 3), and explains
why Ser82 phosphorylation is elevated just after the initiation of
Ser55 phosphorylation (Fig. 4 A). At anaphase, Plk1 binding to
vimentin may be diminished by the reduction of vimentin-Ser55
phosphorylation (Fig. 4 A). However, the elevation of Ser82
phosphorylation appears to continue until the end of mitosis (Fig.
4 A). We consider that this retention may relate to resistance to
the activity of protein phosphatase 1 (PP1), which was reported
to be a vimentin phosphatase (Inada et al., 1999). Interestingly,
phosphoSer82 on vimentin was relatively insensitive to PP1 in
vitro, and the stimulation of a calcium signaling pathway in pri-
mary glia cells resulted in a sustained increase of vimentin-Ser82
phosphorylation (unpublished data). So, phosphoSer82 on vi-
mentin may hardly be dephosphorylated by PP1 in mitosis. This
sustained Ser82 phosphorylation by Plk1 may play some roles in
the efficient segregation of vimentin filaments, although Rho-
kinase and Aurora-B may play greater roles.
This study demonstrates a novel mechanism indicating
that Cdk1 controls vimentin phosphorylation not only by a di-
rect reaction but also through Plk1 recruitment to vimentin.
The crosstalk between Cdk1 and Plk1 signaling opens a new
field to study mechanisms of mitotic regulation.
 
Materials and methods
 
Materials
 
Recombinant mouse vimentin (Ogawara et al., 1995; NCBI accession no.
P20152) and mouse Cdk1 (Kusubata et al., 1992) were purified from
 
Escherichia coli
 
 and FM3A cells, respectively. For Plk1 purification, Sf9
cells were infected with baculovirus carrying His-tagged or GST-tagged
human Plk1-WT or K82R (a kinase dead mutant) for 2 d and then each
protein was purified. In some experiments (Fig. 3), Sf9 cells were further
treated with okadaic acid for 3 h after a 2 d-infection: this method hav-
ing the advantage that Plk1 is already active in Sf9 cells (Kumagai
and Dunphy, 1996). GST-PBD WT or HK538/540AA was purified from
BL21(DE3)pLysS transformed with pGEX-6P-3 carrying residues 326–603
of human Plk1 WT or a mutant in which His538 and Lys540 were
changed into Ala, respectively. Anti-vimentin and site- and phosphoryla-
tion state–specific antibodies of vimentin were prepared as described else-
where (Yasui et al., 2001; Goto et al., 2003). Mammalian expression
vectors of mouse vimentin WT or phosphorylation site mutants were pre-
pared as described previously (Yasui et al., 2001). Interphase and mitotic
U251 cell lysates were prepared as reported by Goto et al. (1998). Plk1-
targeted siRNA duplexes (Liu and Erikson, 2002) were obtained from
QIAGEN. Vimentin peptides (residues 76–85) as shown in Fig. 3 E were
chemically synthesized by Greiner JAPAN.
 
Production of mouse monoclonal anti-Plk1 antibody
 
For the production of the anti-Plk1 mouse monoclonal antibody 36–298,
BALB/c mice were then immunized by repeated injections of 100–150 
 

 
g
of His-tagged human Plk1, using either Freund’s or aluminium hydroxide as
an adjuvant. Spleen cells were fused with PAIB3Ag81 mouse myeloma
cells. Supernatant screening was performed using ELISA and dot-blot assays
with His–tagged human Plk1 as an antigen, and by Western blots on HeLa
S3 extracts. Primary hybridoma clones were subcloned by limiting dilution.
Isotyping revealed that the mouse monoclonal antibody 36–298 is an IgG1.
 
Transfection
 
U251, COS-7, or EBNA-expressing T24 cells (Yasui et al., 2001) were
transfected using Lipofectamine (Invitrogen) or FuGENE (Roche). For siRNA
transfection, U251 cells were transfected using Oligofectamine (Invitrogen)
according to the manufacturer’s instructions. 24 or 48 h after transfection,
cells were subjected to immunocytochemical or immunoblotting studies.
 
Immunofluorescence analysis
 
Immunofluorescence analyses were performed as Goto et al. (1998) with
slight modification. In brief, fluorescence images were visualized using
BX60 microscope (Olympus) controlled by Viewerfinder Lite software (Pix-
Figure 5. The significance of Plk1-induced vimentin phosphorylation on
vimentin filament segregation. (A) T24 cells were transfected with pDR2
carrying vimentin WT or S82E. 48 h after transfection, cells were stained
with anti-vimentin antibody (green) and propidium iodide (red). Magnified
images were also indicated in the right panel. Cells were analyzed by la-
ser-scanning confocal microscopy. (B) Vimentin IF bridge formation and
multinucleate cell in T24 cells expressing vimentin mutants (right). Cells
were stained with anti-vimentin antibody (green) and propidium iodide
(red). The percentage of vimentin IF-bridge or multinucleate cells were
scored as described (Yasui et al., 2001). Data represents means  SEM
in at least three independent experiments. (C) Blue, green, yellow, or red
color represents Plk1, Cdk1, cyclin B, and phosphates within residues on
vimentin, respectively. The red arrow indicates phosphorylation reaction.
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era Corp.) or using Radiance2100 laser confocal microscope controlled
by LaserSharp2000 software (Bio-Rad Laboratories). Confocal images
(captured at 100
 

 
) represents projections of Z series scan (Fig. 5 A).
Other images were captured at 60
 

 
 (by using objective lenses) and re-
corded using a CCD camera (DP50 camera; Olympus).
 
Phosphorylation of proteins and peptides
 
The phosphorylation reaction for vimentin was done in the mixture (25 mM
Tris-Cl, pH 7.5, 1.5 mM MgCl
 
2
 
, 0.1 mM ATP, 0.1 
 

 
M calyculin A, and
150 
 

 
g/ml vimentin) with or without 20 
 

 
g/ml of GST-Plk1 at 25
 

 
C for 60
min. Vimentin phosphorylation by Cdk1 was done as described previously
(Kusubata et al., 1992). Some reactions were done in the presence of
[
 

 
-
 
32
 
P] ATP. The phosphorylation reaction for casein was done as follows:
after 20 
 

 
g/ml GST-Plk1 WT was preincubated with or without 250 
 

 
M
of each peptide in 25 mM Hepes-NaOH, pH 7.5, buffer at RT for 5 min,
phosphorylation reaction was performed in 20 
 

 
l of 25 mM Hepes-
NaOH, pH 7.5, 5 mM MgCl
 
2
 
, 0.1 mM [
 

 
-
 
32
 
P] ATP, 0.1 
 

 
M calyculin A,
200 
 

 
g/ml casein, and the above preincubation mixture (5 
 

 
l) at 30
 

 
C.
The reaction was stopped by the addition of SDS sample buffer and
boiled. The phosphorylation reaction for peptides was performed in the
mixture (25 mM Hepes-NaOH, pH 7.5, 10 mM MgCl
 
2
 
, 50 
 

 
M ATP, 0.1
 

 
M calyculin A, 100 
 

 
M [
 

 
-
 
32
 
P] ATP, 500 
 

 
g/ml each vimentin peptide,
and 60 
 

 
g/ml of purified Plk1) at 25
 

 
C for 60 min. After phosphoryla-
tion, each radioactive peptide was separated by reverse phase-HPLC as
described (Goto et al., 1998).
 
Far Western analysis
 
Vimentin was treated with or without Cdk1 at 25
 

 
C for 60 min. Each reac-
tion mixture was separated by SDS-PAGE and transferred onto mem-
branes. Transferred membranes were incubated with 6 
 

 
g/ml of GST-
PBD-WT or -HK538/540AA in TBS containing 5% skim milk at 4
 

 
C for 6 h.
For peptide competition assay, GST-PBD-WT was preincubated with 100
 

 
g/ml of phosphopeptide PV55 (CSLYASpSPGGVY) or PV41 (CTYSLGp-
SALRPS), unphosphosphorylated peptide V55 (CSLYASSPGGVY), or pep-
tide EV55 (CSLYASEPGGVY; in which Ser55 is changed into Glu) at RT
for 30 min. As a control, GST-PBD-WT was preincubated only with TBS
(no peptide). After washing with TBS, these membranes were incubated
with anti-GST rabbit polyclonal antibody (MBL) and then with HRP-conju-
gated anti–rabbit antibody.
 
GST pull-down assay
 
U251 interphase or mitotic cells were treated with the following buffer
(1 ml): 50 mM Tris-Cl, pH 7.5, 100 mM NaCl, 1 mM EGTA, 1 mM EDTA,
50 mM NaF, 20 mM 
 
	
 
-glycerophosphate, 1 mM Na
 
3
 
VO
 
4
 
, 1% Triton
X-100, and protease inhibitor cocktail (Sigma-Aldrich). After centrifuga-
tion, each cell extract (1 mg total protein) was incubated with 50 
 

 
g of
GST-PBD at 4
 

 
C for 1 h. GST–PBD protein complex were immobilized on
20 
 

 
l of glutathione-sepharose beads, eluted by adding with 20 mM glu-
tathione, and then subjected to immunoblotting with 4A4 (P-Ser55) and
anti-vimentin antibody.
 
Plk1 protein kinase activity toward vimentin pretreated with or without 
Cdk1
 
Vimentin was preincubated with or without Cdk1 at 25
 

 
C for 3 h. Each re-
action mixture was denatured with 7 M urea buffer (7 M urea, 25 mM
Tris-Cl, pH 8.8) at 4
 

 
C for 16 h and then dialyzed with renaturing buffer
(10 mM Tris, 1.7 mM EGTA, 50 mM 2-mercaptoethanol, 1 mM PMSF).
Phosphorylation assay for Plk1 was done as described above.
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